Zhitong Finance App News, Rhine Biotech (002166.SZ) announced that the company received a notice from the controlling shareholder and actual controller, Mr. Qin Benjun, on December 8, 2025. Mr. Qin Benjun is planning a change in control of the company and plans to transfer part of the company's shares to the counterparty by agreement and relinquish voting rights for some of the company's shares held by the counterparty. At present, the parties concerned have signed a “Control Change Intent Agreement” on this matter. Trading of the company's shares has been suspended since the opening of the market on December 10, 2025, and is expected to be suspended for no more than 10 trading days.

Zhitong Finance App News, Rhine Biotech (002166.SZ) announced that the company received a notice from the controlling shareholder and actual controller, Mr. Qin Benjun, on December 8, 2025. Mr. Qin Benjun is planning a change in control of the company and plans to transfer part of the company's shares to the counterparty by agreement and relinquish voting rights for some of the company's shares held by the counterparty. At present, the parties concerned have signed a “Control Change Intent Agreement” on this matter. Trading of the company's shares has been suspended since the opening of the market on December 10, 2025, and is expected to be suspended for no more than 10 trading days.